105 completed, 13 recruiting, 11 terminated, 11 withdrawn. 161 Phase 2, 24 Phase 1, 18 Phase 3.
Follow Autistic Disorder: new trials by email Literature Review of Autistic Disorder trials Research Report on Autistic Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial Evaluating the Effects of Ganaxolone in Children With Autism Ganaxolone (Ztalmy), Placebo - Autism in Children, Autistic Disorder in Children and Adolescents | Phase 2 | Not yet recruiting | Stanford University | 66 | 2027-01-01 | 2026-11-05 |
| A Study to Investigate the Effects and Safety of Codabakalner for the Treatment of FXS in Male Participants and Adult Participants With ADS Codabakalner, Placebo - Fragile X Syndrome (FXS), Autism Spectrum Disorder (ASD) | Phase 2 / Phase 3 | Not yet recruiting | Spinogenix | 120 | 2026-12-01 | 2026-10-09 |
| Role of Omega-DEK in Childhood Apraxia of Speech Omega-DEK, L-carnitine, Placebo - Childhood Apraxia of Speech, Verbal Apraxia | Phase 2 | Not yet recruiting | Claudia R. Morris | 34 | 2026-11-01 | 2026-07-29 |
| TRIal of PPF3 vs. PlaCEbo in the TReatment of Children and AdolescenTs With NeurOdeveloPmental DisorderS PPF3, Placebo - Autism Disorder | Phase 2 | Recruiting | Holland Bloorview Kids Rehabilitation Hospital | 100 | 2026-10-01 | 2026-10-29 |
| Double-Blind Trial of Everolimus for Improving Social Abilities in PTEN Germline Mutations Everolimus blinded oral capsules, Placebo - Cowden's Disease, Cowden's Syndrome | Phase 2 / Phase 3 | Not yet recruiting | Boston Children's Hospital | 60 | 2026-09-01 | 2026-06-04 |
| A Placebo-controlled Trial of Folinic Acid in Children With ASD Folinic Acid, Placebo - Autism Spectrum Disorder | Phase 2 | Recruiting | Prof. Adi Aran | 150 | 2026-06-23 | 2026-06-22 |
| Autism Spectrum Disorder (ASD) Neurodevelopmental Disorder With Issues Social Behavior, Communication Issues, GI Dysfunction. Study is Multimodal Interventions Targeting These Pathways With cSVF, Stored MSCs, FMT and Diet Modification. Role of Autoimmunity, Gut-brain Issues, & Issues Examined. Autologous MSC isolation, concentration, and cryopreservation of adult mesenchymal stem cells, Fecal Biomicrome Transplantation (FMT), Ketogenic RESET Diet Protocol - Autism Spectrum Disorder, Autism | Phase 1 / Phase 2 | Enrolling by invitation | Black Tie Medical, Inc. | 50 | 2026-04-30 | 2026-04-27 |
| Xenon Therapy for Children With Autism Spectrum Disorder Xenon - Autism Spectrum Disorder (ASD), Autism | Phase 1 / Phase 2 | Not yet recruiting | The Children's Hospital of Zhejiang University School of Medicine | 72 | 2026-03-01 | 2026-02-27 |
| Enhancing Orthographic Communication and Literacy Outcomes for AAC Learners ALLSTAR - Literacy, Communication, Nonverbal | Phase 1 / Phase 2 | Not yet recruiting | Penn State University | 60 | 2026-03-01 | 2026-02-03 |
| Propranolol for Aggression, Self-Injury, and Severe Disruptive Behavior in Adolescents and Adults With Autism Propranolol, Placebo - Autism Spectrum Disorder, Challenging Behaviour | Phase 2 | Recruiting | Jeremy Veenstra-vanderweele | 60 | 2026-01-30 | 2026-09-01 |
| Placebo-Controlled Study of Terpenes-Enriched Cannabis Oil T1/C28 for Children With Autism Terpenes-Enriched CBD-Predominant Oil, Placebo, Terpenes-Enriched CBD Oil (THC-Free) - Autism, Autism Spectrum Disorder | Phase 2 | Recruiting | Bazelet Nehushtan LtD. | 78 | 2025-10-05 | 2025-11-19 |
| Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder Pimavanserin Tartrate 34 Mg ORAL CAPSULE [NUPLAZID], Placebo - Autism Spectrum Disorder | Phase 2 | Recruiting | New York State Psychiatric Institute | 30 | 2025-10-01 | 2026-09-02 |
| Treatment Planning for ABA Employing Auxiliary Tools V2+ (TREAAT2+) Tech-enabled ABA treatment planning - Autism Spectrum Disorder | Phase 1 / Phase 2 | Not yet recruiting | Montera Health Texas LLC | 20 | 2025-07-01 | 2024-11-22 |
| Investigating a Marijuana-based Compound as a Treatment for Anxiety in Autistic Adults MB-IMP, Placebo - Autism Spectrum Disorder, Anxiety | Phase 2 | Recruiting | Southwest Autism Research & Resource Center | 108 | 2025-05-28 | 2026-03-30 |
| Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders Sertraline, Placebo - Neurodevelopmental Disorders, Autism | Phase 2 | Recruiting | Holland Bloorview Kids Rehabilitation Hospital | 130 | 2024-09-16 | 2026-07-27 |
| A Study to Evaluate ARD-501 in Patients With Autism Spectrum Disorder Low Dose ARD-501, High Dose ARD-501, Placebo - Autism Spectrum Disorder | Phase 2 | Completed | Aardvark Therapeutics, Inc. | 5 | 2024-08-01 | 2025-05-09 |
| Safety and Efficacy of tPBM for Epileptiform Activity in Autism noninvasively delivered near infra-red (NIR) light - transcranial Photobiomodulation (tPBM) - Autism Spectrum Disorder, EEG With Periodic Abnormalities | Phase 2 | Completed | Richard Frye | 6 | 2024-07-01 | 2026-09-22 |
| Trial of Zolpidem for Sleep in Children With Autism Zolpidem, Placebo - Autism, Autism Spectrum Disorder | Phase 2 | Recruiting | Stanford University | 26 | 2023-08-09 | 2026-03-27 |
| Trial of Diphenhydramine for Sleep in Children With Autism Diphenhydramine, Placebo - Autism, Autism Spectrum Disorder | Phase 2 | Recruiting | Stanford University | 26 | 2023-08-09 | 2026-03-27 |
| Trial of Suvorexant for Sleep in Children With Autism Suvorexant, Placebo - Autism, Autism Spectrum Disorder | Phase 2 | Recruiting | Stanford University | 26 | 2023-08-09 | 2026-03-27 |
Showing 20 of 161. Sign in to see all of them.
Autism Spectrum Disorder (72) · Asperger Syndrome (18) · Child Development Disorders, Pervasive (17) · Anxiety Disorders (9) · Fragile X Syndrome (8) · Communication (4) · Epilepsy (4) · Tuberous Sclerosis (4) · Aggression (3) · Attention Deficit Disorder with Hyperactivity (3) · Intellectual Disability (3) · Learning Disabilities (3) · Neurodevelopmental Disorders (3) · Obsessive-Compulsive Disorder (3)
Mental Disorders (159) · Neurodevelopmental Disorders (158) · Child Development Disorders, Pervasive (144) · Autism Spectrum Disorder (89) · Nervous System Diseases (22) · Neurologic Manifestations (20) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (18) · Neurobehavioral Manifestations (18) · Genetic Diseases, Inborn (17) · Heredodegenerative Disorders, Nervous System (15) · Behavior (14) · Pathological Conditions, Signs and Symptoms (14) · Signs and Symptoms (14) · Congenital Abnormalities (13) · Genetic Diseases, X-Linked (11)
Oxytocin (7) · Everolimus (5) · Memantine (5) · Risperidone (4) · arbaclofen placarbil (4) · Acetylcysteine (3) · Aripiprazole (3) · Cognitive Behavioral Therapy (3) · Donepezil (3) · Sertraline (3) · Valproic Acid (3) · trofinetide (3) · Buspirone (2) · Cannabidiol (2) · Carnitine (2)
Stanford University (12) · Forest Laboratories (5) · Holland Bloorview Kids Rehabilitation Hospital (5) · National Institute of Mental Health (NIMH) (5) · University of California, San Francisco (5) · University of North Carolina, Chapel Hill (5) · Arizona State University (3) · Boston Children's Hospital (3) · Neuren Pharmaceuticals Limited (3) · Seaside Therapeutics, Inc. (3) · Assistance Publique - Hôpitaux de Paris (2) · Chugani, Diane C. (2) · Drexel University College of Medicine (2) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2) · Evdokia Anagnostou (2)
United States (122) · Canada (10) · Israel (7) · France (6) · Italy (4) · Spain (4) · Australia (3) · Belgium (3) · Colombia (3) · Estonia (3) · Hungary (3) · Iceland (3) · New Zealand (3) · Poland (3) · Serbia (3)
Linmarie Sikich, MD (6) · Antonio Hardan, MD (4) · Antonio Y. Hardan, MD (4) · Alexander Kolevzon, MD (3) · Evdokia Anagnostou, M.D. (3) · James B. Adams, PhD (3) · Jeremy Veenstra-VanderWeele, MD (3) · Jordan Lateiner, MS, MBA (3) · Richard P Malone, MD (3) · Robert L Hendren, DO (3) · Alan Percy, MD (2) · Antonio Y. Hardan, M.D. (2) · Bryan King, MD (2) · Craig Erickson, MD (2) · Ephraim Katz, PhD (2)
PMID 37811711, PMID 36006807, PMID 37460385, PMID 38363467, PMID 18315448, PMID 19148734, PMID 19309326, PMID 19487623, PMID 20145986, PMID 20406576, PMID 20683766, PMID 21883204, PMID 22151477, PMID 22342106, PMID 23097920, PMID 23216716, PMID 23357440, PMID 23782126, PMID 23978163, PMID 24061784, PMID 24356715, PMID 24472253, PMID 24849255, PMID 25187257, PMID 25526831, PMID 25685306, PMID 25818246, PMID 25878901, PMID 26746121, PMID 26889605, PMID 27752075, PMID 28374207, PMID 28503116, PMID 28696286, PMID 30196397, PMID 30287612, PMID 31217257, PMID 32660869, PMID 32902182, PMID 33536055, PMID 33927413, PMID 34543081, PMID 34644471, PMID 34658941, PMID 34693989, PMID 35093163, PMID 35395866, PMID 35594551, PMID 36353577, PMID 37011526
P50HD109861 (3), 2009 (1), 2017 (1), 5KL2TR001109-05 (1), P50HD055784 (1), P50MH100023 (1), R01HD091972 (1), R01MH072263 (1), R01MH073524 (1), R21MH064941 (1), R21MH080026 (1), R21NS043979 (1), R34HD065274 (1), R34MH100276 (1), U01HD073984 (1)